Journal of Endocrinology and Metabolism

Editors-in-Chief
Coen D.A. Stehouwer, MD, PhD, FESC
Professor and Chair, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands Read more...
Herbert Herzog
, PhD
Adjunct Professor, Faculty of Medicine, The University of New South Wales, Sydney, Australia
Read more...

ISSN-print: 1923-2861  |  ISSN-online: 1923-287X  |  Bimonthly  | Open Access  | Aims and Scope

Indexed and covered by: Scopus, Chemical Abstract (CA); EBSCO; Worldcat; Google Scholar; Google; JournalTOCs; PubMed: selected citations only (NIH supported articles); Clarivate Analytics Emerging Sources Citation Index (ESCI-Web of Science)

Journal archiving and digital preservation: Portico


Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.
Collection of COVID-19 articles.


Highlights

  • Epicardial Adipose Tissue Thickness as a Reliable Marker of Increased Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

    Epicardial adipose tissue (EAT) is a distinct visceral adipose tissue that is present in between the visceral pericardium and myocardium, in which the coronary arteries are lodged. This tissue releases several inflammatory and atherogenic mediators which lead to the initiation and/or progression of coronary atherosclerosis ...

    Read More >>
  • Association of Diabetes and Severe COVID-19 Outcomes: A Rapid Review and Meta-Analysis

    Addressing the urgent need for evidence on diabetes as a serious comorbidity for severe illness and death from coronavirus disease 2019 (COVID-19), we investigated the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.

    Read More >>
  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

    The presence of nonalcoholic fatty liver diseases (NAFLDs) and type 2 diabetes was associated with elevated risks of cardiovascular events as well as the progression of NAFLD to fibrosis/cirrhosis and hepatocellular carcinoma.

    Read More >>
  • Effects of Policosanol in Patients With Metabolic Syndrome: A Six-Month Study

    The metabolic syndrome comprises a set of cardiovascular risk factors represented by obesity of central distribution, dyslipidemias, glucose metabolism abnormalities and arterial hypertension, closely associated with insulin resistance. The aim of this study is to investigate in the medium term the effects of policosanol in patients with metabolic syndrome, as well as its safety and tolerability.

    Read More >>
  • Acute Pancreatitis in a Patient With Parathyroid Carcinoma

    Parathyroid carcinoma is a rare endocrine malignancy. Clinical features of parathyroid carcinoma are mainly due to the effects of primary hyperparathyroidism (PHPT). Hypercalcemia produced by primary or secondary hyperparathyroidism is a rare and unclear cause of acute pancreatitis.

    Read More >>

Viewpoints

 

 

Featured

 

The Optimal Medical Therapy for Glycemic Control in COVID-19

Diabetes is highly linked to the severity of coronavirus disease 2019 (COVID-19). My recent meta-analysis also suggested a higher prevalence of diabetes in severe COVID-19 as compared with non-severe COVID-19. Recent observational studies have shown that hyperglycemia was significantly associated with severity of COVID-19 in both diabetic and non-diabetic patients. Full Text

Luteinizing Hormone to Follicle-Stimulating Hormone Ratio Significantly Correlates With Androgen Level and Manifestations Are More Frequent With Hyperandrogenemia in Women With Polycystic Ovary Syndrome

Altered luteinizing hormone to follicle-stimulating hormone (LH-FSH) ratio and hyperandrogenism are two important pathophysiological characteristics of polycystic ovary syndrome (PCOS). Full Text


Image of the Issue

 

Giant Prolactinomas: Case Series and Review of the Literature
Giant prolactinomas can pose unique diagnostic and management challenges because of atypical presentations and confounding laboratory assessments. We present four cases of giant prolactinomas each presenting in a unique manner and discuss the diagnostic and management dilemmas associated with them. Full Text


Current Issue

 


Vol. 11, No. 1, Feb 2021

Table of Contents

Review

The Optimal Medical Therapy for Glycemic Control in COVID-19 Abstract HTML PDF
Hidekatsu Yanai 1-7
doi: https://doi.org/10.14740/jem718

Original Article

Comparison of Metformin and Alogliptin Fixed-Dose Tablets Once a Morning Versus Once an Evening Using Continuous Glucose Monitoring (AMPM Study): An Open-Label Randomized Cross-Over Trial Abstract HTML PDF
Futoshi Ebara, Masayuki Domichi, Akiko Suganuma, Naoki Sakane 8-13
doi: https://doi.org/10.14740/jem720
Luteinizing Hormone to Follicle-Stimulating Hormone Ratio Significantly Correlates With Androgen Level and Manifestations Are More Frequent With Hyperandrogenemia in Women With Polycystic Ovary Syndrome Abstract HTML PDF
Md. Shahed Morshed, Hurjahan Banu, Nazma Akhtar, Tania Sultana, Afroza Begum, Moriom Zamilla, Sadiqa Tuqan, Sukanti Shah, Ahmed Hossain, Shazia Afrine, Emran Ur Rashid, Iffat Ara Jahan, M.A. Hasanat 14-21
doi: https://doi.org/10.14740/jem716
Dietary Factors Associated With Dyslipidemia Traits in Individuals With Impaired Glucose Tolerance Abstract HTML PDF
Naoki Sakane, Akiko Suganuma, Hideshi Kuzuya 22-27
doi: https://doi.org/10.14740/jem721

Short Communication

The Role of Inflammation in Contributing to Vascular Risk in Subclinical Hyperthyroidism: Randomized Controlled Trial Abstract HTML PDF
Shaikh Abdul Kader Kamaldeen Abdul Shakoor, Hong Li Jiao, Alvin Wai Kit Tan, Liew Huiling 28-32
doi: https://doi.org/10.14740/jem723
 

Browse  Journals  

 

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.             
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.